Skip to main content
Erschienen in: Journal of General Internal Medicine 8/2019

22.04.2019 | Clinical Practice: Clinical Vignettes

Pneumococcal Bacteremia Complicated by Hemophagocytic Lymphohistiocytosis

verfasst von: Frederick Howard, MD, Christopher Sankey, MD, FACP, SFHM

Erschienen in: Journal of General Internal Medicine | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

From pneumonia to pericarditis, from sepsis to splenic abscess, Streptococcus pneumoniae is the causative agent of a diverse array of pyogenic disease. With the introduction of vaccines and effective antibiotic treatments, the incidence of complicated streptococcal infection has declined. We report a case of S. pneumoniae bacteremia, in the setting of occult sinusitis, complicated by hemophagocytic lymphohistiocytosis (HLH), disseminated intravascular coagulation (DIC), and recurrent pneumococcal infection. Although severe streptococcal infection has been associated with immunodeficiency or splenectomy, no such predisposition was identified in our patient. We discuss the association of streptococcal infection with HLH and DIC and review occult sinusitis as a source of pneumococcal bacteremia, with the goal of enhancing the “illness scripts” of general medical practitioners to include such entities.
Literatur
1.
Zurück zum Zitat Watson DA, Musher DM, Jacobson JW, Verhoef J. A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin Infect Dis 1993;17(5):913–24.CrossRef Watson DA, Musher DM, Jacobson JW, Verhoef J. A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin Infect Dis 1993;17(5):913–24.CrossRef
3.
Zurück zum Zitat Taylor SN, Sanders CV. Unusual manifestations of invasive pneumococcal infection. Am J Med 1999;107(1A):12S–27S.CrossRef Taylor SN, Sanders CV. Unusual manifestations of invasive pneumococcal infection. Am J Med 1999;107(1A):12S–27S.CrossRef
4.
Zurück zum Zitat Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Hamborsky J, Kroger A, Wolfe S, eds. 13th ed. Washington D.C. Public Health Foundation, 2015. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Hamborsky J, Kroger A, Wolfe S, eds. 13th ed. Washington D.C. Public Health Foundation, 2015.
5.
Zurück zum Zitat Alanee SR, Mcgee L, Jackson D, et al. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 2007;45(1):46–51.CrossRef Alanee SR, Mcgee L, Jackson D, et al. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 2007;45(1):46–51.CrossRef
6.
Zurück zum Zitat Yin Z, Rice BD, Waight P, et al. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009. AIDS (London, England) 2012; 26(1):87–94.CrossRef Yin Z, Rice BD, Waight P, et al. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009. AIDS (London, England) 2012; 26(1):87–94.CrossRef
7.
Zurück zum Zitat Lipsky BA, Boyko EJ, Inui TS, Koepsell TD. Risk factors for acquiring pneumococcal infections. Arch Intern Med 1986;146(11):2179–85.CrossRef Lipsky BA, Boyko EJ, Inui TS, Koepsell TD. Risk factors for acquiring pneumococcal infections. Arch Intern Med 1986;146(11):2179–85.CrossRef
8.
Zurück zum Zitat Rubin LG, Schaffner W. Clinical practice. Care of the asplenic patient. N Engl J Med 2014;371(4):349–56.CrossRef Rubin LG, Schaffner W. Clinical practice. Care of the asplenic patient. N Engl J Med 2014;371(4):349–56.CrossRef
9.
Zurück zum Zitat Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008;9(5):503–10.CrossRef Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008;9(5):503–10.CrossRef
10.
Zurück zum Zitat Baranek T, Morello E, Valayer A, et al. FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection. Front Immunol 2017;8:123.CrossRef Baranek T, Morello E, Valayer A, et al. FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection. Front Immunol 2017;8:123.CrossRef
11.
Zurück zum Zitat Meiring S, Cohen C, Quan V, et al. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV). PLoS One 2016;11(2):e0149104.CrossRef Meiring S, Cohen C, Quan V, et al. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV). PLoS One 2016;11(2):e0149104.CrossRef
12.
Zurück zum Zitat Raz R, Elhanan G, Shimoni Z, et al. Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Israeli Adult Pneumococcal Bacteremia Group. Clin Infect Dis 1997;24(6):1164–8.CrossRef Raz R, Elhanan G, Shimoni Z, et al. Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Israeli Adult Pneumococcal Bacteremia Group. Clin Infect Dis 1997;24(6):1164–8.CrossRef
13.
Zurück zum Zitat Hariri MA, Vice PA. Septic shock and death due to occult sinusitis. J Laryngol Otol 1990;104(12):990.CrossRef Hariri MA, Vice PA. Septic shock and death due to occult sinusitis. J Laryngol Otol 1990;104(12):990.CrossRef
14.
Zurück zum Zitat Van zanten AR, Dixon JM, Nipshagen MD, De bree R, Girbes AR, Polderman KH. Hospital-acquired sinusitis is a common cause of fever of unknown origin in orotracheally intubated critically ill patients. Crit Care 2005;9(5):R583–90.CrossRef Van zanten AR, Dixon JM, Nipshagen MD, De bree R, Girbes AR, Polderman KH. Hospital-acquired sinusitis is a common cause of fever of unknown origin in orotracheally intubated critically ill patients. Crit Care 2005;9(5):R583–90.CrossRef
15.
Zurück zum Zitat Ah-see KW, Evans AS. Sinusitis and its management. BMJ. 2007;334(7589):358–61.CrossRef Ah-see KW, Evans AS. Sinusitis and its management. BMJ. 2007;334(7589):358–61.CrossRef
16.
Zurück zum Zitat Bisno AL, Freeman JC. The syndrome of asplenia, pneumococcal sepsis, and disseminated intravascular coagulation. Ann Intern Med 1970;72(3):389–93.CrossRef Bisno AL, Freeman JC. The syndrome of asplenia, pneumococcal sepsis, and disseminated intravascular coagulation. Ann Intern Med 1970;72(3):389–93.CrossRef
17.
Zurück zum Zitat De souza AL, Sztajnbok J, Salgado MM, et al. Severe myalgia of the lower extremities as the first clinical feature of meningococcal purpura fulminans. Am J Trop Med Hyg 2007;77(4):723–6.CrossRef De souza AL, Sztajnbok J, Salgado MM, et al. Severe myalgia of the lower extremities as the first clinical feature of meningococcal purpura fulminans. Am J Trop Med Hyg 2007;77(4):723–6.CrossRef
18.
Zurück zum Zitat Emori K, Takeuchi N, Soneda J. A Case of Waterhouse-Friderichsen Syndrome Resulting from an Invasive Pneumococcal Infection in a Patient with a Hypoplastic Spleen. Case Rep Crit Care 2016;2016:4708086.PubMedPubMedCentral Emori K, Takeuchi N, Soneda J. A Case of Waterhouse-Friderichsen Syndrome Resulting from an Invasive Pneumococcal Infection in a Patient with a Hypoplastic Spleen. Case Rep Crit Care 2016;2016:4708086.PubMedPubMedCentral
19.
Zurück zum Zitat Valade S, Azoulay E, Galicier L, et al. Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis. Medicine (Baltimore) 2015;94(40):e1692.CrossRef Valade S, Azoulay E, Galicier L, et al. Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis. Medicine (Baltimore) 2015;94(40):e1692.CrossRef
21.
Zurück zum Zitat Cone LA, B Waterbor R, Sofonio MV. Purpura fulminans due to Streptococcus pneumoniae sepsis following gastric bypass. Obes Surg 2004;14(5):690–4.CrossRef Cone LA, B Waterbor R, Sofonio MV. Purpura fulminans due to Streptococcus pneumoniae sepsis following gastric bypass. Obes Surg 2004;14(5):690–4.CrossRef
22.
Zurück zum Zitat Teo HG, Wong JY, Ting TLL. Purpura Fulminans: A rare presentation of Streptococcus Pneumoniae infection. BMJ Case Rep 2017;2017:bcr-2017-221150.CrossRef Teo HG, Wong JY, Ting TLL. Purpura Fulminans: A rare presentation of Streptococcus Pneumoniae infection. BMJ Case Rep 2017;2017:bcr-2017-221150.CrossRef
23.
Zurück zum Zitat Komatsu M, Ishihara T, Manabe S, et al. A Case of Overwhelming Postsplenectomy Infection Caused by Streptococcus pneumoniae with Fulminant Purpura. Tokai J Exp Clin Med 2017;42(3):130–132.PubMed Komatsu M, Ishihara T, Manabe S, et al. A Case of Overwhelming Postsplenectomy Infection Caused by Streptococcus pneumoniae with Fulminant Purpura. Tokai J Exp Clin Med 2017;42(3):130–132.PubMed
24.
Zurück zum Zitat Asakura T, Higuchi A, Mori N. Streptococcus pneumoniae-induced purpura fulminans. QJM. 2016;109(7):499–500.CrossRef Asakura T, Higuchi A, Mori N. Streptococcus pneumoniae-induced purpura fulminans. QJM. 2016;109(7):499–500.CrossRef
25.
Zurück zum Zitat Alvarez EF, Olarte KE, Ramesh MS. Purpura Fulminans Secondary to Streptococcus pneumoniae Meningitis. Case Rep Infect Dis 2012;2012:508503.PubMedPubMedCentral Alvarez EF, Olarte KE, Ramesh MS. Purpura Fulminans Secondary to Streptococcus pneumoniae Meningitis. Case Rep Infect Dis 2012;2012:508503.PubMedPubMedCentral
26.
Zurück zum Zitat Bisno AL, Freeman JC. The Syndrome of Asplenia, Pneumococcal Sepsis, and Disseminated Intravascular Coagulation. Ann Intern Med 72(3):389. Bisno AL, Freeman JC. The Syndrome of Asplenia, Pneumococcal Sepsis, and Disseminated Intravascular Coagulation. Ann Intern Med 72(3):389.
27.
Zurück zum Zitat Ondruschka B, Habeck JO, Hädrich C, Dreßler J, Bayer R. Rare cause of natural death in forensic setting: hemophagocytic syndrome. Int J Legal Med 2016;130(3):777–81.CrossRef Ondruschka B, Habeck JO, Hädrich C, Dreßler J, Bayer R. Rare cause of natural death in forensic setting: hemophagocytic syndrome. Int J Legal Med 2016;130(3):777–81.CrossRef
28.
Zurück zum Zitat François B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor Am J Med 1997;103(2):114–20.CrossRef François B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor Am J Med 1997;103(2):114–20.CrossRef
29.
Zurück zum Zitat Otrock ZK, Hock KG, Riley SB, De witte T, Eby CS, Scott MG. Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis. Ann Hematol 2017;96(10):1667–1672.CrossRef Otrock ZK, Hock KG, Riley SB, De witte T, Eby CS, Scott MG. Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis. Ann Hematol 2017;96(10):1667–1672.CrossRef
30.
Zurück zum Zitat Grangé S, Buchonnet G, Besnier E, et al. The Use of Ferritin to Identify Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis. Crit Care Med 2016;44(11):e1045-e1053.CrossRef Grangé S, Buchonnet G, Besnier E, et al. The Use of Ferritin to Identify Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis. Crit Care Med 2016;44(11):e1045-e1053.CrossRef
31.
Zurück zum Zitat Greinacher A, Selleng S. How I evaluate and treat thrombocytopenia in the intensive care unit patient. Blood. 2016;128(26):3032–3042.CrossRef Greinacher A, Selleng S. How I evaluate and treat thrombocytopenia in the intensive care unit patient. Blood. 2016;128(26):3032–3042.CrossRef
32.
Zurück zum Zitat Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118(15):4041–4052.CrossRef Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118(15):4041–4052.CrossRef
33.
Zurück zum Zitat Raschke RA, Garcia-orr R. Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults. Chest. 2011;140(4):933–938.CrossRef Raschke RA, Garcia-orr R. Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults. Chest. 2011;140(4):933–938.CrossRef
Metadaten
Titel
Pneumococcal Bacteremia Complicated by Hemophagocytic Lymphohistiocytosis
verfasst von
Frederick Howard, MD
Christopher Sankey, MD, FACP, SFHM
Publikationsdatum
22.04.2019
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 8/2019
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05001-x

Weitere Artikel der Ausgabe 8/2019

Journal of General Internal Medicine 8/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.